Literature DB >> 16892344

Synthesis and structure-activity relationships of FAAH inhibitors: cyclohexylcarbamic acid biphenyl esters with chemical modulation at the proximal phenyl ring.

Giorgio Tarzia1, Andrea Duranti, Giuseppe Gatti, Giovanni Piersanti, Andrea Tontini, Silvia Rivara, Alessio Lodola, Pier Vincenzo Plazzi, Marco Mor, Satish Kathuria, Daniele Piomelli.   

Abstract

Fatty acid amide hydrolase (FAAH) is a serine hydrolase that catalyzes the intracellular hydrolysis of fatty acid ethanolamides such as anandamide and oleoylethanolamide. Targeting this enzyme may have important therapeutic potentials owing to the multiple physiological roles of these amides. Cyclohexylcarbamic acid biphenyl-3-yl ester (URB524) was one of the most promising FAAH inhibitors so far described. We report the modulation of the electronic and steric features of the proximal phenyl ring of this compound by introducing a series of substituents at the ortho and para positions. pIC50 values were found to correlate with molecular features thought to be involved in the recognition step such as steric hindrance and hydrogen-bonding ability. Derivatives with small polar groups at the para position of the proximal phenyl ring were slightly better FAAH inhibitors than the parent compound URB524.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16892344     DOI: 10.1002/cmdc.200500017

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  23 in total

1.  Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fatty acid amide hydrolase.

Authors:  Jessica K DeMartino; Joie Garfunkle; Dustin G Hochstatter; Benjamin F Cravatt; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2008-06-28       Impact factor: 2.823

2.  Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase.

Authors:  F Anthony Romero; Wu Du; Inkyu Hwang; Thomas J Rayl; F Scott Kimball; Donmienne Leung; Heather S Hoover; Richard L Apodaca; J Guy Breitenbucher; Benjamin F Cravatt; Dale L Boger
Journal:  J Med Chem       Date:  2007-02-06       Impact factor: 7.446

3.  A second generation of carbamate-based fatty acid amide hydrolase inhibitors with improved activity in vivo.

Authors:  Jason R Clapper; Federica Vacondio; Alvin R King; Andrea Duranti; Andrea Tontini; Claudia Silva; Silvano Sanchini; Giorgio Tarzia; Marco Mor; Daniele Piomelli
Journal:  ChemMedChem       Date:  2009-09       Impact factor: 3.466

4.  Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stability.

Authors:  Federica Vacondio; Claudia Silva; Alessio Lodola; Caterina Carmi; Silvia Rivara; Andrea Duranti; Andrea Tontini; Silvano Sanchini; Jason R Clapper; Daniele Piomelli; Giorgio Tarzia; Marco Mor
Journal:  Eur J Med Chem       Date:  2011-07-21       Impact factor: 6.514

5.  O-(triazolyl)methyl carbamates as a novel and potent class of fatty acid amide hydrolase (FAAH) inhibitors.

Authors:  Giampiero Colombano; Clara Albani; Giuliana Ottonello; Alison Ribeiro; Rita Scarpelli; Glauco Tarozzo; Jennifer Daglian; Kwang-Mook Jung; Daniele Piomelli; Tiziano Bandiera
Journal:  ChemMedChem       Date:  2014-10-22       Impact factor: 3.466

6.  Fluoride-mediated capture of a noncovalent bound state of a reversible covalent enzyme inhibitor: X-ray crystallographic analysis of an exceptionally potent α-ketoheterocycle inhibitor of fatty acid amide hydrolase.

Authors:  Mauro Mileni; Joie Garfunkle; Cyrine Ezzili; Benjamin F Cravatt; Raymond C Stevens; Dale L Boger
Journal:  J Am Chem Soc       Date:  2011-02-28       Impact factor: 15.419

7.  Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics.

Authors:  Cyrine Ezzili; Mauro Mileni; Nicholas McGlinchey; Jonathan Z Long; Steven G Kinsey; Dustin G Hochstatter; Raymond C Stevens; Aron H Lichtman; Benjamin F Cravatt; Edward J Bilsky; Dale L Boger
Journal:  J Med Chem       Date:  2011-03-23       Impact factor: 7.446

8.  Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH).

Authors:  Douglas S Johnson; Kay Ahn; Suzanne Kesten; Scott E Lazerwith; Yuntao Song; Mark Morris; Lorraine Fay; Tracy Gregory; Cory Stiff; James B Dunbar; Marya Liimatta; David Beidler; Sarah Smith; Tyzoon K Nomanbhoy; Benjamin F Cravatt
Journal:  Bioorg Med Chem Lett       Date:  2009-03-24       Impact factor: 2.823

9.  X-ray crystallographic analysis of alpha-ketoheterocycle inhibitors bound to a humanized variant of fatty acid amide hydrolase.

Authors:  Mauro Mileni; Joie Garfunkle; Cyrine Ezzili; F Scott Kimball; Benjamin F Cravatt; Raymond C Stevens; Dale L Boger
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

10.  Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.

Authors:  Marco Migliore; Damien Habrant; Oscar Sasso; Clara Albani; Sine Mandrup Bertozzi; Andrea Armirotti; Daniele Piomelli; Rita Scarpelli
Journal:  Eur J Med Chem       Date:  2015-12-23       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.